Education
About Us
Working with TipRanks
Follow Us
KARADANOTE INC. (JP:4014)
:4014
Top Page
KARADANOTE INC.
(4014)
Select Model
Select Model
Rating:50Neutral
Price Target:
¥480.00
▲(0.00% Upside)
KARADANOTE INC. is currently facing substantial financial difficulties, with declining revenues and negative profitability being the most significant concerns. While technical analysis shows some short-term bullish momentum, the valuation remains unattractive due to significant losses. The absence of earnings call data and corporate events limits additional insights into the company's future prospects.
Positive Factors
Business Model Diversification
KARADANOTE INC.'s diversified revenue streams from subscriptions, device sales, and partnerships provide resilience against market fluctuations, supporting long-term stability.
Debt Management
Improved debt-to-equity ratio indicates better leverage management, enhancing financial stability and reducing risk of financial distress.
Industry Position
KARADANOTE INC.'s focus on digital health positions it well in a growing industry, with increasing demand for health tech solutions supporting long-term growth.
Negative Factors
Revenue Decline
The significant revenue decline indicates challenges in market demand or competitive positioning, potentially impacting long-term sustainability and growth.
Profitability Issues
Persistent profitability issues reflect operational inefficiencies or pricing challenges, which could hinder long-term financial performance and investor confidence.
Cash Flow Weakness
Weak cash flow generation raises concerns about KARADANOTE INC.'s ability to sustain operations and invest in growth without external financing.
KARADANOTE INC. (4014) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥3.05B
Dividend YieldN/A
Average Volume (3M)13.65K
Price to Earnings (P/E)―
Beta (1Y)0.94
Revenue Growth-51.54%
EPS Growth-111.68%
CountryJP
Employees45
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)4.97
Shares Outstanding6,697,900
10 Day Avg. Volume6,780
30 Day Avg. Volume13,653
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)6.41
Price to Sales (P/S)2.42
P/FCF Ratio-26.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
KARADANOTE INC. Business Overview & Revenue Model
Company DescriptionKARADANOTE INC. (4014) is a technology company specializing in health and wellness solutions. It operates primarily in the digital health sector, focusing on developing innovative applications and platforms that enhance personal well-being through data analysis and user engagement. The company's core products include a suite of health monitoring applications, wearable fitness devices, and personalized health management services designed to empower users to track and improve their health metrics.
How the Company Makes MoneyKARADANOTE INC. generates revenue through multiple streams, including subscription services for its health monitoring applications, direct sales of wearable fitness devices, and partnerships with healthcare providers and insurance companies. The subscription model allows users to access premium features and personalized health insights for a recurring fee. Additionally, the company collaborates with health organizations to offer tailored wellness programs, which provides another significant source of income. Advertising partnerships and data analytics services also contribute to its overall earnings by leveraging anonymized user data to provide insights for health-related research and marketing initiatives.
KARADANOTE INC. Financial Statement Overview
Summary
KARADANOTE INC. shows solid revenue growth and improved leverage management. However, profitability and cash flow challenges persist, with a low net profit margin and negative free cash flow.Income Statement
KARADANOTE INC. has shown significant revenue growth with a Revenue Growth Rate of 6.7% from 2023 to 2024. The Gross Profit Margin improved to 67.6% in 2024, indicating strong cost management. However, there are concerns with profitability as the Net Profit Margin is 5.2%, which is relatively low for the industry. The EBIT Margin at 4.6% reflects challenges in managing operating expenses.Balance Sheet
The company's Debt-to-Equity Ratio decreased to 0.85, indicating improved leverage management. However, the Return on Equity (ROE) is 32.6%, which is strong but driven by a lower equity base. The Equity Ratio stands at 34.1%, suggesting moderate reliance on debt financing.Cash Flow
The Free Cash Flow remains negative at -110.4 million, although the Operating Cash Flow improved compared to the previous year. The Operating Cash Flow to Net Income Ratio is negative, highlighting cash flow challenges despite reported net income.| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.27B | 1.27B | 2.19B | 2.06B | 1.31B | 1.00B |
| Gross Profit | 619.71M | 619.00M | 1.48B | 1.52B | 916.51M | 760.43M |
| EBITDA | -71.21M | -51.91M | 102.11M | -370.80M | -312.56M | 214.28M |
| Net Income | -68.72M | -69.00M | 114.89M | -372.46M | -271.73M | 139.05M |
Balance Sheet | ||||||
| Total Assets | 768.00M | 768.00M | 1.03B | 1.09B | 1.38B | 1.14B |
| Cash, Cash Equivalents and Short-Term Investments | 596.00M | 596.00M | 483.48M | 686.65M | 1.04B | 964.94M |
| Total Debt | 200.00M | 200.00M | 300.00M | 400.00M | 500.00M | 0.00 |
| Total Liabilities | 288.00M | 288.00M | 683.03M | 866.14M | 746.67M | 169.96M |
| Stockholders Equity | 480.00M | 480.00M | 352.65M | 376.75M | 573.00M | 967.85M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -116.00M | -110.37M | -258.22M | -349.08M | 163.79M |
| Operating Cash Flow | 0.00 | -115.00M | -107.37M | -255.41M | -346.91M | 185.22M |
| Investing Cash Flow | 0.00 | 143.00M | -3.00M | -2.81M | -3.79M | -32.34M |
| Financing Cash Flow | 0.00 | 84.63M | -92.80M | -93.45M | 424.09M | 497.06M |
KARADANOTE INC. Technical Analysis
Negative
480.00
Price Trends
460.10
Negative
466.99
Negative
472.52
Negative
Market Momentum
-0.69
Negative
48.17
Neutral
73.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4014, the sentiment is Negative. The current price of 480 is above the 20-day moving average (MA) of 463.60, above the 50-day MA of 460.10, and above the 200-day MA of 472.52, indicating a bearish trend. The MACD of -0.69 indicates Negative momentum. The RSI at 48.17 is Neutral, neither overbought nor oversold. The STOCH value of 73.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4014.
KARADANOTE INC. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥4.33B | 7.22 | ― | ― | -7.31% | 287.94% | |
69 Neutral | ¥3.29B | 15.51 | ― | ― | 13.48% | 61.77% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥2.99B | 11.32 | ― | 1.05% | -3.21% | ― | |
50 Neutral | ¥3.05B | -424.15 | ― | ― | -51.54% | -111.68% | |
44 Neutral | ¥16.64B | 87.34 | ― | ― | 56.35% | ― |
* Technology Sector Average
JP:4014
KARADANOTE INC.
456.00
35.00
8.31%
JP:2334
Eole, Inc.
435.00
387.50
815.79%
JP:3710
Jorudan Co., Ltd.
581.00
-7.97
-1.35%
JP:3744
SIOS Corp
500.00
125.00
33.33%
JP:5256
Fusic Co.,Ltd.
2,569.00
-416.00
-13.94%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.